Effects and mechanisms of Stauntonia brachyanthera Hand.-Mazz against Alzheimer's disease through network pharmacology and experimental validation
Biochemical and Biophysical Research Communications · 2026-10 · 836 · 154546
DOI: 10.1016/j.bbrc.2026.154546 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biochemical and Biophysical Research Communications, 2026-10. Verfasst von Jiaxin Wang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Sino-Pakistan Center on Traditional Chinese Medicine, School of Basic Medical Sciences, School of Pharmaceutical Sciences, School of Nursing, Huaihua…. Hauptthemen laut MEDLINE: Alzheimer Disease, Neuroprotective Agents, Plant Extracts, Drugs, Chinese Herbal. Die Arbeit nennt 53 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Themen: Demenz
Abstract (Originalsprache)
Stauntonia brachyanthera Hand.-Mazz. (SB), a traditional medicinal plant of the Dong ethnic group with nutraceutical applications, exhibits broad-spectrum pharmacological activity. However, the therapeutic effects and mechanisms of SB on Alzheimer's disease (AD) remain unclear. This study aims to investigate the neuroprotective potential and underlying mechanisms of SB against AD. We utilized network pharmacology and molecular docking to predict the active components, targets, and pathways of SB associated with AD treatment. Gene Ontology (GO) enrichment and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis were further used to identify potential therapeutic targets and underlying mechanisms of SB in relation to AD. Then, the neuroprotective effects, neuronal differentiation-promoting activity and potential mechanism of key active components of SB on the main therapeutic targets were verified by in vitro experiments. The network pharmacological prediction results showed that the treatment of AD with SB was closely related to MAPK and PI3K/Akt pathways. Further experiments showed that the SB active component kaempferol (KMF) alleviated Aβ1-42-induced injury and promoted neuronal differentiation. Additionally, we found that KMF-mediated promotion of neuronal differentiation in N2a cells was dependent on the PI3K/Akt and MAPK pathways. In this study, we employed a combined computational-experimental approach to elucidate the neuroprotective mechanisms of SB against Alzheimer's disease. We further validated KMF as a key active component of SB that alleviates Aβ1-42-induced injury and promotes neuronal differentiation through the PI3K/Akt and MAPK pathways.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Sino-Pakistan Center on Traditional Chinese Medicine, School of Basic Medical Sciences, School of Pharmaceutical Sciences, School of Nursing, Huaihua Key Laboratory of Ion Channels and Complex Diseases, Hunan University…
- Graduate School of Guangzhou Medical University, Guangzhou, 510000, China.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Wang, J., Pu, H., Peng, L., Cai, S., Ding, Q., Chen, X., Liu, Y., Xiong, W., Liao, Y., & Tang, G. (2026). Effects and mechanisms of Stauntonia brachyanthera Hand.-Mazz against Alzheimer's disease through network pharmacology and experimental validation. Biochemical and Biophysical Research Communications, 836, 154546. https://doi.org/10.1016/j.bbrc.2026.154546
Vancouver
Wang J, Pu H, Peng L, Cai S, Ding Q, Chen X, et al. Effects and mechanisms of Stauntonia brachyanthera Hand.-Mazz against Alzheimer's disease through network pharmacology and experimental validation. Biochemical and Biophysical Research Communications. 2026;836:154546. doi:10.1016/j.bbrc.2026.154546
BibTeX
@article{Wang2026,
author = {Wang, Jiaxin and Pu, Hong and Peng, Lingsheng and Cai, Shichang and Ding, Qi and Chen, Xiaoyong and Liu, Yang and Xiong, Wenchao and Liao, Yumei and Tang, Genyun},
title = {Effects and mechanisms of Stauntonia brachyanthera Hand.-Mazz against Alzheimer's disease through network pharmacology and experimental validation},
journal = {Biochemical and Biophysical Research Communications},
year = {2026},
volume = {836},
pages = {154546},
doi = {10.1016/j.bbrc.2026.154546}
}
EUVIMED